Objective (s): Helicobacter pylori (H. pylori) is a pathogenic bacterium that colonizes the
stomachs of approximately 50% of the world's population. Resistance of H. pylori to …

Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures.
Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the …

Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections,
affecting almost half of the world's population. It is associated with peptic ulcer disease …

Background: Antimicrobials have been useful in the treatment of H. pylori-related dyspeptic
diseases. However, emergence of resistant strains often decreases the eradication rates of …

Background Treatment success of H. pylori eradication therapy has declined worldwide
largely because of increased antimicrobial resistance. New therapeutic approaches are …

BACKGROUND: Vitamin C in gastric juice and in vitro has been shown to inhibit the growth
of Helicobacter pylori (H. pylori). AIMS: The purpose of this study was to investigate the effect …

Results: Following furazolidone-based first-line therapy, H. pylori eradication rates were
75.7% and 79.6% at ITT and PP analysis, respectively (P< 0.001). The overall incidence of …

Objective: Helicobacter pylori infection is associated with a wide range of gastrointestinal
diseases and is very common in developing countries. Overuse and self-prescribed …

The efficacy of first-and second-line Helicobacter pylori (H. pylori) eradication regimens
varies considerably in West Asian countries, mainly due to the variable prevalence of …

Background/aims: Furazolidone has been introduced as an effective drug against
Helicobacter pylori infection in Iran, but intolerable side effects may limit its use. The aim of …